AHEAD Medicine Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AHEAD Medicine's estimated annual revenue is currently $1.6M per year.(i)
  • AHEAD Medicine's estimated revenue per employee is $162,000

Employee Data

  • AHEAD Medicine has 10 Employees.(i)
  • AHEAD Medicine grew their employee count by -44% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is AHEAD Medicine?

We focus on developing AI-enabled diagnostics and clinical decision support for blood cancers. Our vision is to provide efficient, comprehensive and high fidelity diagnostic and disease evaluation solutions to support physicians in optimizing treatment plan for patients with hematologic malignancies.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.6M

Revenue (est)

-44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AHEAD Medicine News

2022-04-20 - Atrium Health Navicient's Food as Medicine Market is ...

For an appointment with Food as Medicine, call ahead at 478-633-5656 and they will set up convenient appointments times for potential...

2022-04-20 - The Global Wellness Summit Announces the "Future of Functional Medicine Symposium" in Bangkok on May 20th-in Partnership with Miskawaan Health Group

... researchers and wellness experts presenting on what's ahead for functional medicine–with topics ranging from new integrative approaches...

2022-03-22 - University of Iowa moves ahead with search for new medical vice president and dean

Chris Cooper, urology professor and senior associate dean for medical education. Nkanyezi Ferguson, clinical associate professor of dermatology.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M10-33%N/A
#2
$0.6M100%N/A
#3
$0.9M100%N/A
#4
$0.9M10-37%N/A
#5
$0.9M10-9%N/A